HSDT Helius Medical Technologies: Business Value

Official company branding of Helius Medical Technologies, Inc. (HSDT)

This chart of trades on the GURU.Markets platform demonstrates the business value dynamics of Helius Medical (HSDT), which currently stands at 134.61. Helius Medical (HSDT) is developing a network of clinics for motor recovery following traumatic brain injuries. The production cycle is based on eco-friendly materials and the minimization of emissions. Stability in device output is ensured through the creation of microchip reserves and partnerships with US contractors.

HSDT (heliusmedical.com) Total Company Value history from 11/23/2025 to 10/27/2026

Helius Medical Technologies (HSDT) - metric breakdowns and financial figures

- price and consensus price forecast:
Market Chart Helius Medical Technologies, Inc.|HSDT - Analyst Consensus Forecast
- market capitalization data:
Market Capitalization Helius Medical Technologies|HSDT - Real Price to Acquire Entire Company
- book capitalization data:
Book Price of a Share Helius Medical Technologies|HSDT - Company Book Value|Capitalization to Book Value Ratio heliusmedical.com|HSDT - Company Total Assets
- debt and liquidity data:
Debt to Capital Helius Medical|HSDT - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Helius Medical Technologies, Inc.|HSDT - Company Debts|Debt to Net Assets Ratio Helius Medical Technologies
Comprehensive company analysis:Helius Medical (HSDT)
Mass-produced product of Helius Medical Technologies

Professional asset selection begins with an analysis of the business's real value under a full buyout. This metric aggregates market capitalization and net debt, excluding cash from the valuation. The trend in total enterprise value allows for an assessment of the investment attractiveness of Helius Medical (HSDT). The company's value is supported by unique neuromodulation patents. Clinical efficacy and insurance mechanisms ensure the stability of this fundamental indicator.

Direct competitors

Company Buyout Price Biogen Inc BIIB|Neurocrine Biosciences Inc (NBIX) - Enterprise Value|Regencell Corp (RGC) - Business Value|AXSM - Real Price to Acquire Entire Company|ACAD (acadia-pharm.com) - Aggregate Business Value|Total Company Value Xenon (XENE)|Business Value Viking Therapeutics Inc|Supernus Pharma - Enterprise Value|Total Enterprise Value Catalyst Corp CPRX|Real Price to Acquire Entire Company DNLI (Denali Therapeutics)|harmonybiosciences.com - Enterprise Value|Total Company Value Biohaven (BHVN)|AMLX: Value Adjusted for Debt and Cash|Total Company Value TRVI|Praxis Corp (PRAX) - Total Enterprise Value|AVXL - Enterprise Value|Value Adjusted for Debt and Cash ceribell.com|Prothena Biosciences - Enterprise Value|Total Enterprise Value ALEC (alector.com)|Total Company Value Annexon Inc. ANNX|Total Company Value Omeros Corp OMER|Enterprise Value NGNE (Neurogene Inc.)|acimmune.com (ACIU) - Company Buyout Price|VYGR: Real Price to Acquire Entire Company|NMRA (Neumora) - Enterprise Value|SCLX: Total Company Value|Company Buyout Price Tevogen Bio Inc. (TVGN)|Alpha Cognition (ACOG) - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash CGTX (Cognition Therapeutics Inc.)|Inhibikase Therapeutics, Inc. - Total Company Value|Real Price to Acquire Entire Company Cassava Sciences Inc SAVA|ASRT (Assertio Therapeutics) - Enterprise Value|COYA - Total Enterprise Value|Enterprise Value vistagen.com|Ovid Therapeutics (OVID) - Business Value|ABOS: Enterprise Value|Company Buyout Price CervoMed, Inc.|Enterprise Value ATHE (Alterity Therapeutics)|Real Price to Acquire Entire Company clene.com (CLNN)|Enterprise Value PEPG (PepGen)|Jupiter Neurosciences, Inc. - Enterprise Value|RLMD - Total Company Value|ANVS - Total Company Value|Enterprise Value gracetx.com GRCE|AIFF (Firefly Neuro) - Value Adjusted for Debt and Cash|KLTO: Total Company Value|Company Buyout Price NeuroSense Therapeutics, Ltd.|Enterprise Value Reviva Pharmaceuticals Holdings, Inc. RVPH|Business Value metaviatx.com MTVA|Real Price to Acquire Entire Company NeurAxis, Inc (NRXS)|Passage Bio Inc. - Aggregate Business Value|Neuphoria (NEUP) - Total Company Value|NERV - Business Value|Enterprise Value ATHA|Total Enterprise Value Addex Therapeutics Ltd.|ALZN (Alzamend Neuro Inc.) - Real Price to Acquire Entire Company|Enterprise Value CYCN|Protagenic Therapeutics (PTIX) - Total Company Value|Value Adjusted for Debt and Cash KTTA (pasitheaclinics.com)|CRGT: Total Company Value|Total Enterprise Value Avenue Therapeutics Inc. ATXI|Enterprise Value Brainstorm Cell Therapeutics, Inc. (BCLI)|CARA - Value Adjusted for Debt and Cash|Enterprise Value CHRO|ELYM (Eliem Therapeutics Inc.) - Total Enterprise Value|Total Company Value Intra-Cellular Therapies Inc.|Total Company Value Longboard Pharmaceuticals Inc|MRNS (Marinus) - Enterprise Value|Company Buyout Price NKGen Biotech Corp NKGN|Real Price to Acquire Entire Company NRBO (NeuroBo Pharmaceuticals)|sagerx.com - Enterprise Value|Total Company Value SNPX (Synaptogenix)|Trevena Inc. (TRVN) - Company Buyout Price|Real Price to Acquire Entire Company vigilneuro.com VIGL|WENA (anewmeds.com) - Value Adjusted for Debt and Cash|Total Company Value CERE